Log in to save to my catalogue

Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer th...

Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer th...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_19264968

Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy

About this item

Full title

Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2009-03, Vol.106 (12), p.4822-4827

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

The poor prognosis of patients with aggressive and invasive cancers combined with toxic effects and short half-life of currently available treatments necessitate development of more effective tumor selective therapies. Mesenchymal stem cells (MSCs) are emerging as novel cell-based delivery agents; however, a thorough investigation addressing their...

Alternative Titles

Full title

Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmed_primary_19264968

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_19264968

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.0806647106

How to access this item